chronic myelogenous leukemia
"The drug has been effective but since Medicare coverage changed this year the out of pocket expense of $2k / month makes it not affordable.  The best hope was the copay program offered by Novartis but since I have a Part D plan (as bad as it is) I do not qualify for that.  Oh well, I had a good run.  Hopeful that it somehow stays in remission, but if not hopeful that it does not drag out."